Assessment scales for the anticholinergic effects of drugs;échelles d'évaluation de l'effet anticholinergique des médicaments

NPG Neurologie - Psychiatrie - Geriatrie

Volumn 12, Issue 69, 2012, Pages 131-138

  Mebarki, S ^a   Trivalle, C ^b  

^a AP HP ^*  (France)

^b HÔPITAL PAUL BROUSSE   (France)

Author keywords

Anticholinergic medication; Cognition; Elderly; Iatrogenic

Indexed keywords

EID: 84861951779     PISSN: 16274830     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npg.2012.03.002     Document Type: Article

References (33)

1. Laroche M.L., Bouthier F., Merle L., et al. Médicaments potentiellement inappropriés aux personnes âgées: intérêt d'une liste adaptée à la pratique médicale française. Rev Med Interne 2009, 7:592-601.
2. Fick D.M., Cooper J.W., Wade W.E., et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Int Med 2003, 22:2716-2724.
3. Flacker J.M., Virginia C., Mach J.R., et al. The association of serum anticholinergic activity with delirium in elderly medical patients. Am J Geriatr Psychiatry 1998, 6:31-41.
4. Mulsant B.H., Pollock B.G., Kirshner M., et al. Serum anticholinergic activity in a community-based sample of older adults. Arch Gen Psychiatry 2003, 60:198-203.
5. Tune L.E. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry 2001, 62(Suppl. 21):11-14.
6. Dyer C.B., Ashton C.M., Teasdale T.A. Postoperative delirium: a review of 80 primary data collection studies. Arch Intern Med 1995, 155:461-465.
7. Lechevallier-Michel N., Molimard M., Dartigues J.F., et al. Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID study. Br J Clin Pharmacol 2005, 59:143-151.
8. Lieberman J.A. Managing anticholinergic side effects. Prim Care Companion J Clin Psychiatry 2004, 6(Suppl. 2):20-23.
9. Bodineau-Mobaraka A., Veille-Finet A., Giacobbi A., Folliguet M. Polymédication et sécheresse buccale chez le sujet âgé. Rev Fr Geriatr Gerontol 2006, XIII(127):396-399.
10. Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging 1993, 3:335-348.
11. Gauthier J., Morais J.A., Malle L. Impact des vagues de chaleur en gériatrie et risques associés aux médicaments. Pharmactuel 2005, 38:123-133.
12. Kibourne E.M., Choi K., Jones T.S., Thacker S.B. Risk factors for heatstroke: a case control study. JAMA 1982, 247:3332-3336.
13. Han L., McCusker J., Cole M., et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical patients. Arch Intern Med 2001, 161:1099-1105.
14. Carriere I., Fourrier-Reglat A., Dartigues J.F., et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population, the 3-city study. Arch Intern Med 2009, 169:1317-1324.
15. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982, 217:408-414.
16. Tune L., Carr S., Hoag E., et al. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am J Psychiatry 1992, 149:1393-1394.
17. Mulsant B.H., Pollock B.G., Kirshner M., et al. Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry 2003, 60:198-203.
18. Rudd K.M., Raehl C.L., Bond C.A., et al. Methods for assessing drug-related anticholinergic activity. Pharmacotherapy 2005, 1592-1601.
19. Tune L., Carr S., Cooper T. Association of anticholinergic activity of prescribed medications with postoperative delirium. J Neuropsychiatry Clin Neurosci 1993, 5:208-210.
20. Carnahan R.M., Lund B.C., Perry P.J., Pollock B.G. A critical appraisal of the utility of the serum anticholinergic activity assay in research and clinical practice. Psychopharmacol Bull 2002, 36:24-39.
21. Rudolph J.L., Salow M.J., Angelini M.C., McGlinchey R.E. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008, 16:508-513.
22. Boustani M.A., Campbell N.L., Munger S., et al. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health 2008, 4:311-320.
23. Carnahan R.M., Lund B.C., Perry P.J., et al. The relationship of an anticholinergic rating scale with serum anticholinergic activity in elderly nursing home residents. Psychopharmacol Bull 2002, 36:14-19.
24. Carnahan R.M., Lund B.C., Perry P.J., et al. The anticholinergic drug scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol 2006, 46:1481-1486.
25. Richelson E. Preclinical pharmacology of neuroleptics: focus on new generation compounds. J Clin Psychiatry 1996, 57(Suppl. 11):4-11.
26. Bymaster F.P., Nelson D.L., DeLapp N.W., et al. Antagonism by olanzapine of dopamine D1, serotonin 2, muscarinic, histamine H1, and alpha 1-adrenergic receptors in vitro. Schizophr Res 1999, 37:107-122.
27. Chengappa K.N., Pollock B.G., Parepally H., et al. Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine. J Clin Psychopharmacol 2000, 20:311-316.
28. Lim C.J., Trevino C., Tampi R.R. Can olanzapine cause delirium in the elderly?. Ann Pharmacother 2006, 40:135-138.
29. Kennedy J.S., Bymaster F.P., Schuh L., et al. A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data. Int J Geriatr Psychiatry 2001, 16(Suppl. 1):S33-S61.
30. Zhang W., Bymaster F.P. The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors. Psychopharmacology (Berl) 1999, 141:267-278.
31. Sanchez C., Hyttel J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 1999, 19:467-489.
32. Stein R.A., Strickland T.L. A review of the neuropsychological effects of commonly used prescription medications. Arch Clin Neuropsychol 1998, 13:259-284.
33. Pollock B.G., Mulsant B.H., Nebes R., et al. Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline. Am J Psychiatry 1998, 155:1110-1112.